YOLFTbeta
00

Dezhan HealthCare Co Ltd

000813 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

2.80CNY-0.08 (-2.78%)

Price History

Full chart

Market Stats

Previous Close2.88
Open2.88
Day Range2.79 – 2.90
52-Week Range2.75 – 4.73
Volume21.96M
Market Cap6.77B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.17
Dividend Yield0.00%
Beta0.38
50-Day Avg3.36
200-Day Avg3.54

About

Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People's Republic of China. The company offers atorvastatin calcium tablets, amlodipine-atorvastatin calcium tablets, warfarin sodium tablets, trimetazidine hydrochloride tablets, amiodarone hydrochloride tablets, as well as other drugs, including famciclovir tablets, azathioprine tablets, hydroxyurea tablets, colchicine tablet, and oseltamivir phosphate capsules. It also involved in the provision of biopeptides, industrial hemp, and medical service business. Dezhan Healthcare Company Limited was founded in 1980 and is based in Beijing, the People's Republic of China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Wei Liu
  • Employees1.07K
  • HeadquartersFirst Shanghai Center, Beijing, China, 100025, China
  • Websitehttps://www.dezhanhealthcare.com

Leadership

  • Mr. Wei LiuCo-Chairman & GM · b. 1970

Financials

Income Statement

Currency: CNY1995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue311.09M368.87M412.90M467.81M466.64M456.11M292.04M372.10M379.16M338.63M358.08M317.08M328.95M374.43M248.88M296.63M299.03M302.32M561.75M994.96M1.18B1.44B2.22B3.29B1.77B962.87M734.48M570.86M498.09M466.49M396.81M
Growth (%)-+18.57%+11.94%+13.30%-0.25%-2.26%-35.97%+27.41%+1.90%-10.69%+5.74%-11.45%+3.74%+13.83%-33.53%+19.19%+0.81%+1.10%+85.81%+77.12%+18.52%+22.36%+53.87%+48.22%-46.06%-45.75%-23.72%-22.28%-12.75%-6.34%-14.94%
Cost of Revenue207.03M230.07M271.37M324.94M313.23M373.69M281.14M318.61M398.24M274.38M289.63M254.00M272.70M317.39M219.51M213.46M239.35M70.28M109.39M176.63M181.02M222.90M224.55M245.57M375.14M294.39M261.42M359.44M223.13M170.39M173.98M
Gross Profit104.06M138.79M141.53M142.87M153.41M82.43M10.90M53.48M-19.08M64.25M68.45M56.96M56.25M57.04M29.37M83.18M61.41M751.61M928.60M818.34M998.25M1.22B2.00B3.05B1.40B668.47M473.06M211.41M274.96M296.09M222.83M
Gross Margin33.45%37.63%34.28%30.54%32.88%18.07%3.73%14.37%-5.03%18.97%19.12%17.96%17.10%15.23%11.80%28.04%20.54%248.62%165.30%82.25%84.65%84.55%89.89%92.54%78.86%69.43%64.41%37.03%55.20%63.47%56.15%
Operating Expense64.16M90.20M76.71M70.82M76.15M70.57M154.03M50.02M161.03M247.54M62.88M46.82M46.54M41.42M81.25M82.44M67.21M773.53M799.40M389.17M392.60M444.78M1.06B1.99B1.02B315.99M510.25M330.24M194.73M338.57M396.36M
Operating Income39.90M48.59M64.82M72.04M77.26M11.86M-143.13M3.47M-180.11M-183.29M5.57M10.13M9.71M15.62M-51.89M738.71K-5.80M-21.92M129.19M429.17M605.65M775.32M938.78M1.05B380.04M352.49M-37.19M-118.82M80.22M-42.48M-173.53M
Operating Margin12.83%13.17%15.70%15.40%16.56%2.60%-49.01%0.93%-47.50%-54.13%1.56%3.20%2.95%4.17%-20.85%0.25%-1.94%-7.25%23.00%43.13%51.36%53.73%42.28%32.01%21.41%36.61%-5.06%-20.81%16.11%-9.11%-43.73%
EBITDA64.50M89.89M93.97M111.13M106.75M66.33M-98.23M48.94M-147.72M-132.39M37.63M30.63M33.49M19.37M-40.22M20.05M26.33M245.94M229.91M451.76M640.56M794.23M948.10M1.08B357.46M302.53M127.85M-64.27M25.70M-1.32M-326.56M
EBITDA Margin20.73%24.37%22.76%23.76%22.88%14.54%-33.64%13.15%-38.96%-39.10%10.51%9.66%10.18%5.17%-16.16%6.76%8.80%81.35%40.93%45.40%54.32%55.04%42.70%32.68%20.14%31.42%17.41%-11.26%5.16%-0.28%-82.30%
Net Income39.70M48.34M50.00M60.96M68.42M10.85M-145.00M5.52M-204.37M-179.07M9.90M12.46M16.93M2.20M-46.65M6.32M3.47M-9.48M26.26M354.87M509.20M661.67M797.18M930.53M336.92M284.54M-57.58M-46.95M83.31M-20.41M-345.42M
Net Income Margin12.76%13.11%12.11%13.03%14.66%2.38%-49.65%1.48%-53.90%-52.88%2.76%3.93%5.15%0.59%-18.74%2.13%1.16%-3.14%4.67%35.67%43.18%45.85%35.90%28.28%18.98%29.55%-7.84%-8.22%16.73%-4.38%-87.05%
R&D-----------------17.70M34.70M31.57M36.55M51.83M54.65M86.68M118.57M56.05M67.06M51.49M51.10M79.00M82.28M
R&D as % of Total Revenue-----------------5.85%6.18%3.17%3.10%3.59%2.46%2.63%6.68%5.82%9.13%9.02%10.26%16.93%20.73%
Interest Expense25.89M43.51M33.63M27.68M20.93M33.26M29.11M25.31M30.85M23.78M15.32M2.84M3.62M3.50M1.49M4.78M11.55M7.72M23.60M18.57M17.42M3.47M613.00K116.79K5.41M5.59M5.48M4.68M1.17M727.98K2.31M
Interest Expense % of Total Revenue8.32%11.80%8.14%5.92%4.48%7.29%9.97%6.80%8.14%7.02%4.28%0.89%1.10%0.93%0.60%1.61%3.86%2.55%4.20%1.87%1.48%0.24%0.03%0.00%0.30%0.58%0.75%0.82%0.24%0.16%0.58%

Balance Sheet

Currency: CNY1995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets945.30M956.52M1.09B1.13B1.15B1.36B1.22B1.22B1.06B727.81M597.31M578.04M590.94M541.74M516.28M639.31M668.82M594.73M1.90B2.03B1.97B3.93B5.14B5.92B5.93B6.40B5.78B5.67B5.38B5.32B4.87B
Total Liabilities661.93M663.82M751.97M515.39M506.21M707.22M566.67M547.41M582.97M431.68M270.09M127.13M120.89M63.09M92.67M214.05M239.89M179.54M490.48M679.75M599.40M175.37M593.57M640.15M316.15M446.37M308.05M390.38M137.15M154.88M299.50M
Total Equity277.92M288.12M330.90M607.64M635.47M645.23M643.91M649.47M443.91M273.35M309.77M434.15M451.01M454.62M406.13M411.89M415.21M401.70M1.14B1.06B1.06B3.75B4.55B5.28B5.61B5.90B5.37B5.29B5.24B5.16B4.64B
Cash70.27M47.90M67.65M86.03M110.82M91.68M121.77M122.00M102.40M107.45M96.57M91.91M69.41M77.74M141.65M192.20M148.32M46.58M52.25M150.04M148.60M1.69B1.92B1.44B1.48B2.41B1.47B2.60B2.80B2.53B1.81B
Total Debt342.83M409.72M492.85M303.81M308.16M551.35M426.74M383.61M422.17M326.91M183.02M50.25M44.03M2.14M40.66M160.48M181.41M115.51M316.89M378.94M333.38M384.00K384.00K6.29M5.00M56.95M12.36M9.07M5.50M14.65M-
Net Debt272.56M361.81M425.20M217.77M197.34M459.67M304.98M261.61M319.77M219.46M86.45M-41.66M-25.38M-75.60M-100.99M-31.72M33.09M68.93M264.64M228.90M184.78M-1.69B-1.92B-1.44B-1.48B-2.36B-1.46B-2.59B-2.79B-2.52B-

Cash Flow

Currency: CNY1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow101.00M53.15M-41.16M-67.96M31.98M-5.88M44.73M134.83M22.62M-6.88M56.53M36.03M-40.29M-17.50M16.51M170.59M136.47M124.91M262.36M384.64M379.78M1.56B827.54M42.41M161.72M127.87M-14.59M4.72M
Investing Cash Flow-63.86M-1.41M-168.28M22.77M11.71M-29.33M72.47M-420.64K4.06M2.72M-5.56M-9.20M-24.38M-35.74M-44.11M-85.06M-80.93M-57.63M-77.25M-145.79M-665.08M-1.52B-544.54M96.47M1.01B178.02M-179.38M-
Financing Cash Flow-18.48M-27.01M203.42M74.95M-43.57M15.64M-112.16M-145.29M-31.35M-18.34M-42.64M37.09M115.22M9.37M-74.15M-147.66M41.58M-68.96M1.38B-194.45M-194.45M-5.55M54.03M-488.39M-48.12M-160.11M-78.09M-
Capital Expenditure15.50M35.86M8.08M20.01M20.07M7.89M13.24M952.24K1.16M4.22M8.16M10.35M28.05M44.70M44.67M85.17M81.01M61.92M74.96M112.05M68.56M65.08M110.28M126.92M67.56M159.73M166.55M235.99M
Free Cash Flow85.50M17.29M-49.23M-87.97M11.91M-13.77M31.49M133.88M21.47M-11.10M48.36M25.68M-68.35M-62.21M-28.16M85.42M55.45M62.99M187.40M272.59M311.23M1.49B717.25M-84.51M94.16M-31.86M-181.14M-231.27M
Dividends Paid44.28M24.66M36.77M28.69M25.24M30.89M17.30M4.11M2.84M3.77M3.50M1.43M4.61M11.56M8.24M24.05M20.47M15.90M4.97M30.87K30.87K30.87K30.87K470.29M-29.12K79.75K1.48M
FCF to OCF84.65%32.53%119.62%129.44%37.24%234.14%70.40%99.29%94.89%161.32%85.56%71.28%169.62%355.39%-170.56%50.07%40.64%50.43%71.43%70.87%81.95%95.82%86.67%-199.28%58.23%-24.91%1241.62%-4897.13%
Dividend Paid to FCF51.79%142.66%-74.69%-32.61%211.92%-224.38%54.93%3.07%13.22%-34.01%7.23%5.58%-6.74%-18.58%-29.27%28.15%36.91%25.25%2.65%0.01%0.01%0.00%0.00%-556.47%--0.09%-0.04%-0.64%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Aug 27, 2014Oct 22, 2014Mar 23, 2015Apr 29, 2015Aug 28, 2015Oct 27, 2015Mar 13, 2016Apr 27, 2016Aug 27, 2016Oct 30, 2016Dec 31, 2016Apr 14, 2017Aug 18, 2017Oct 27, 2017Dec 31, 2017Apr 20, 2018Aug 24, 2018Oct 26, 2018Dec 31, 2018Apr 27, 2019Aug 24, 2019Oct 24, 2019Dec 31, 2019Apr 28, 2020Aug 29, 2020Oct 31, 2020Dec 31, 2020Apr 29, 2021Aug 30, 2021Nov 1, 2021Dec 31, 2021Apr 30, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023May 8, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 8, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------------------------------------------------------
EPS Actual-0.000.010.00-0.09-0.000.010.010.00-0.00-0.01-0.010.02-0.00-0.02-0.010.02-0.01-0.02-0.020.080.010.010.04-0.030.010.000.00-0.00-0.01-0.020.280.200.070.120.090.070.080.120.130.090.050.050.04-0.000.040.040.030.020.030.020.01-0.080.010.020.00-0.050.00-0.000.030.01-0.010.01-0.00-0.01-0.01-0.01-0.01-0.14-0.02-0.01
Surprise----------------------------------------------------------------------
Timing---------------------After-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-market-Pre-marketAfter-hoursPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketAfter-hours-Pre-market-------Pre-market-------After-hours---After-hours-----

Key Statistics & Ratios

Market Cap6.77B
Enterprise Value5.56B
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales18.16
Price / Book1.48
EPS-0.17
Book Value2.18
Revenue (TTM)373.09M
Gross Profit (TTM)169.91M
EBITDA-148.50M
Profit Margin-96.68%
Operating Margin-111.49%
Return on Equity-9.20%
Return on Assets-2.86%
Shares Outstanding2.10B
Shares Float1.34B
Beta0.38
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20211×
0.21Jun 1, 2021

Stock Splits

  • May 24, 201715:10
  • May 4, 19991.8:1